Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1965 1
1973 2
1975 1
1979 1
1980 3
1981 1
1982 1
1983 1
1986 2
1988 4
1989 7
1990 3
1991 3
1992 7
1993 4
1994 8
1995 11
1996 13
1997 7
1998 10
1999 9
2000 8
2001 7
2002 5
2003 12
2004 9
2005 18
2006 13
2007 20
2008 20
2009 15
2010 15
2011 23
2012 20
2013 14
2014 26
2015 19
2016 16
2017 15
2018 10
2019 12
2020 12
2021 15
2022 10
2023 19
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

401 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Hirschfield GM, et al. Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6. Hepatology. 2023. PMID: 37386786 Free PMC article. Clinical Trial.
Doege-Potter syndrome.
Torres Gómez A, García Alabarce AM, García Castro JM, Navas Bueno B, Rueda Villafranca B, Fernández JL. Torres Gómez A, et al. Among authors: fernandez jl. Endocrinol Diabetes Nutr (Engl Ed). 2023 Oct;70(8):556-557. doi: 10.1016/j.endien.2023.06.005. Epub 2023 Oct 17. Endocrinol Diabetes Nutr (Engl Ed). 2023. PMID: 37858413 No abstract available.
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J; DALI Study. Roberts JA, et al. Clin Infect Dis. 2014 Apr;58(8):1072-83. doi: 10.1093/cid/ciu027. Epub 2014 Jan 14. Clin Infect Dis. 2014. PMID: 24429437
[Hepatitis C].
Viola LA, Fernández JL. Viola LA, et al. Among authors: fernandez jl. Acta Gastroenterol Latinoam. 1992;22(2):133-4. Acta Gastroenterol Latinoam. 1992. PMID: 1338677 Spanish. No abstract available.
[Assessing sperm DNA damage].
Cortés-Gutiérrez EI, Dávila-Rodríguez MI, López-Fernández C, Fernández JL, Gosálvez J. Cortés-Gutiérrez EI, et al. Among authors: fernandez jl. Actas Urol Esp. 2007 Feb;31(2):120-31. doi: 10.1016/s0210-4806(07)73609-4. Actas Urol Esp. 2007. PMID: 17645091 Review. Spanish.
Response: Nitroblue tetrazolium (NBT) assay.
Gosálvez J, Fernández JL, Esteves SC. Gosálvez J, et al. Among authors: fernandez jl. Reprod Biomed Online. 2018 Jan;36(1):92-93. doi: 10.1016/j.rbmo.2017.09.007. Epub 2017 Oct 5. Reprod Biomed Online. 2018. PMID: 29174918 No abstract available.
401 results